Objectives: This study aims to assess the role of transforming growth factor-beta 1 (TGF-β1) in systemic lupus erythematosus (SLE). Patients and methods: The study included 40 female SLE patients (mean age 25.5±6.2 years; range 15 to 39 years) diagnosed according to the American College of Rheumatology criteria and 30 female healthy controls (mean age 26.2±5.9 years; range 16 to 39 years). Disease activity was assessed using SLE Disease Activity Index. Patients were diagnosed with lupus nephritis if they met the criteria for renal disorder. SLE patients and controls were compared in terms of TGF-β1, low and high density lipoprotein, and triglyceride levels. Results: Mean serum TGF-β1 level of patients with SLE was 1385.7±483.1 pg/mL, with a significant difference compared to control group (2079.6±125.4 pg/mL; p
Systemic lupus erythematosus (SLE) is an autoimmune multi-systemic disease with heterogeneous manifestations. It is well known that polyserositis is common in SLE patients, particularly pleural and pericardial affection; however, peritoneal affection is not so common.(1) This should raise our suspicions to exclude other causes of ascites in SLE patients particularly if ascites is recurrent or massive. In this article, we report the case of a 43-year-old female patient with SLE with lupus nephritis diagnosed 15 years ago based on clinical findings including musculoskeletal and renal manifestations, positive antinuclear antibodies and anti-double stranded deoxyribonucleic acid with consumed complement 3 and 4. Patient was prescribed hydroxychloroquine, steroids, cyclophosphamide and mycophenolate mofetil. She presented to us with lupus activity in form of autoimmune hemolytic anemia with a history of recurrent massive ascites and bilateral pleural effusion. The condition prompted us to search for the causes of refractory ascites which might be malignant or infectious, or tuberculosis (TB) in particular, after ruling out renal, cardiac, hepatic etiologies. A written informed consent was obtained from the patient. We performed extended investigations that showed normal blood albumin level. Tumor markers were significant only for an elevated serum cancer antigen 125 (CA-125) (80 U/L normal
Background: Vitamin D has an immunomodulatory action through binding to vitamin D receptor (VDR) which might be affected by VDR gene polymorphisms. In this study, we investigated serum levels of 25- hydroxyvitamin D3 and the VDR gene polymorphisms (Fokl, Bsml) in Egyptian BD patients and their relationship to disease manifestations and activity.